Vero Biotech Revenue and Competitors

Claim your profile

Atlanta, GA USA

Location

$204.6M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Vero Biotech's estimated annual revenue is currently $48.2M per year.(i)
  • Vero Biotech received $14.6M in venture funding in October 2013.
  • Vero Biotech's estimated revenue per employee is $251,250
  • Vero Biotech's total funding is $204.6M.

Employee Data

  • Vero Biotech has 192 Employees.(i)
  • Vero Biotech grew their employee count by -6% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$18.9M9424%N/AN/A
#2
$4.7M5758%N/AN/A
#3
$14.7M730%N/AN/A
#4
$16.1M9737%N/AN/A
#5
$8.4M42-7%N/AN/A
#6
$46.2M23022%N/AN/A
#7
$0.4M4300%$50MN/A
#8
$16.5M8228%N/AN/A
#9
$3.4M418%N/AN/A
#10
$15.9M797%N/AN/A

Vero biotech is an emerging biotechnology company focused on the design, development, and commercialization of next generation inhaled nitric oxide (NO) delivery systems to address unmet medical needs of patients with cardiopulmonary conditions. At Vero Biotech, our mission is to improve the lives of patients by leading the development of innovative technologies for inhaled NO delivery in the acute care hospital setting and beyond, wherever Nitric Oxide treatment is needed. We strive to exceed customer expectations in terms of safety, efficacy, and growth by focusing on the science, development, and commercialization of our innovations.

keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals

$204.6M

Total Funding

192

Number of Employees

$48.2M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Vero Biotech News

2022-04-06 - Georgia Bio Names 2022 Golden Helix Award Winners

VERO Biotech. Public Financing. Kennesaw State University. Community Awards: Presented to a small number of individuals, companies or...

2021-01-20 - Vero Biotech Secures $50M in Funding

Vero Biotech LLC, an Atlanta, Georgia-based biotechnology company, closed a senior secured term loan of $50m. Runway Growth Capital provided the financing. Led by Brent V. Furse, CEO and President, Vero Biotech (formerly known as GeNO LLC) is a biotechnology company focused on the design, deve ...

2021-01-12 - Runway Growth Capital Announces a Senior Secured Term Loan of $50 Million to VERO Biotech

WOODSIDE, Calif., Jan. 12, 2021 /PRNewswire/ -- Runway Growth Capital LLC ("Runway"), a leading provider of growth loans to both venture and non-venture backed companies seeking an alternative to raising equity, today announced the close of a senior secured term loan of $50 million to VERO Bio ...

2019-02-03 - Lehigh alumni aim to change medicine forever

Lehigh alumni Rory Siegel, '18, and Liam Walsh, '17, are translating the skills gained as undergraduates to their work at Vero Biotech, where ...

2018-10-05 - Vero Biotech Names Michael Gentile as Vice President of ...

ATLANTA, Oct. 5, 2018 /PRNewswire/ -- Vero Biotech LLC, a biopharmaceutical company focused on the design, development and ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$33.8M19231%N/A
#2
$57M19219%N/A
#3
$43.3M1923%$400.4M
#4
$29.6M192106%N/A
#5
$31.5M19227%N/A

Vero Biotech Funding

DateAmountRoundLead InvestorsReference
2013-10-08$14.6MUndisclosedArticle